137 related articles for article (PubMed ID: 38114668)
1. Editorial Expression of Concern: Altered neuregulin 1-erbB4 signaling contributes to NMDA> receptor hypofunction in schizophrenia.
Hahn CG; Wang HY; Cho DS; Talbot K; Gur RE; Berrettini WH; Bakshi K; Kamins J; Borgmann-Winter KE; Siegel SJ; Gallop RJ; Arnold SE
Nat Med; 2024 Mar; 30(3):911. PubMed ID: 38114668
[No Abstract] [Full Text] [Related]
2. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia.
Hahn CG; Wang HY; Cho DS; Talbot K; Gur RE; Berrettini WH; Bakshi K; Kamins J; Borgmann-Winter KE; Siegel SJ; Gallop RJ; Arnold SE
Nat Med; 2006 Jul; 12(7):824-8. PubMed ID: 16767099
[TBL] [Abstract][Full Text] [Related]
3. Perinatal phencyclidine treatment alters neuregulin 1/erbB4 expression and activation in later life.
du Bois TM; Newell KA; Huang XF
Eur Neuropsychopharmacol; 2012 May; 22(5):356-63. PubMed ID: 21962913
[TBL] [Abstract][Full Text] [Related]
4. Neuregulin 1-erbB4 pathway in schizophrenia: From genes to an interactome.
Banerjee A; Macdonald ML; Borgmann-Winter KE; Hahn CG
Brain Res Bull; 2010 Sep; 83(3-4):132-9. PubMed ID: 20433909
[TBL] [Abstract][Full Text] [Related]
5. Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors.
Pitcher GM; Kalia LV; Ng D; Goodfellow NM; Yee KT; Lambe EK; Salter MW
Nat Med; 2011 Apr; 17(4):470-8. PubMed ID: 21441918
[TBL] [Abstract][Full Text] [Related]
6. Positive and negative symptoms in schizophrenia: the NMDA receptor hypofunction hypothesis, neuregulin/ErbB4 and synapse regression.
Bennett M
Aust N Z J Psychiatry; 2009 Aug; 43(8):711-21. PubMed ID: 19629792
[TBL] [Abstract][Full Text] [Related]
7. Schizophrenia: more evidence for less glutamate.
Morrison PD; Pilowsky LS
Expert Rev Neurother; 2007 Jan; 7(1):29-31. PubMed ID: 17187494
[TBL] [Abstract][Full Text] [Related]
8. The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity.
Li B; Woo RS; Mei L; Malinow R
Neuron; 2007 May; 54(4):583-97. PubMed ID: 17521571
[TBL] [Abstract][Full Text] [Related]
9. Neuregulin 1 Type I Overexpression Is Associated with Reduced NMDA Receptor-Mediated Synaptic Signaling in Hippocampal Interneurons Expressing PV or CCK.
Kotzadimitriou D; Nissen W; Paizs M; Newton K; Harrison PJ; Paulsen O; Lamsa K
eNeuro; 2018; 5(2):. PubMed ID: 29740596
[TBL] [Abstract][Full Text] [Related]
10. Sub-chronic Antipsychotic Drug Administration Reverses the Expression of Neuregulin 1 and ErbB4 in a Cultured MK801-Induced Mouse Primary Hippocampal Neuron or a Neurodevelopmental Schizophrenia Model.
Li C; Tang Y; Yang J; Zhang X; Liu Y; Tang A
Neurochem Res; 2016 Aug; 41(8):2049-64. PubMed ID: 27097547
[TBL] [Abstract][Full Text] [Related]
11. The origin of NMDA receptor hypofunction in schizophrenia.
Nakazawa K; Sapkota K
Pharmacol Ther; 2020 Jan; 205():107426. PubMed ID: 31629007
[TBL] [Abstract][Full Text] [Related]
12. A neuregulin 1 transmembrane domain mutation causes imbalanced glutamatergic and dopaminergic receptor expression in mice.
Newell KA; Karl T; Huang XF
Neuroscience; 2013 Sep; 248():670-80. PubMed ID: 23811072
[TBL] [Abstract][Full Text] [Related]
13. A negative feedback loop controls NMDA receptor function in cortical interneurons via neuregulin 2/ErbB4 signalling.
Vullhorst D; Mitchell RM; Keating C; Roychowdhury S; Karavanova I; Tao-Cheng JH; Buonanno A
Nat Commun; 2015 Jun; 6():7222. PubMed ID: 26027736
[TBL] [Abstract][Full Text] [Related]
14. Expressions of neuregulin 1beta and ErbB4 in prefrontal cortex and hippocampus of a rat schizophrenia model induced by chronic MK-801 administration.
Feng Y; Wang XD; Guo CM; Yang Y; Li JT; Su YA; Si TM
J Biomed Biotechnol; 2010; 2010():859516. PubMed ID: 20467458
[TBL] [Abstract][Full Text] [Related]
15. Neuregulin 1 Controls Glutamate Uptake by Up-regulating Excitatory Amino Acid Carrier 1 (EAAC1).
Yu HN; Park WK; Nam KH; Song DY; Kim HS; Baik TK; Woo RS
J Biol Chem; 2015 Aug; 290(33):20233-44. PubMed ID: 26092725
[TBL] [Abstract][Full Text] [Related]
16. Cre-Activation in ErbB4-Positive Neurons of Floxed
Mallien AS; Pfeiffer N; Vogt MA; Chourbaji S; Sprengel R; Gass P; Inta D
Front Psychiatry; 2021; 12():750106. PubMed ID: 34899420
[TBL] [Abstract][Full Text] [Related]
17. Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia.
Nakazawa K; Jeevakumar V; Nakao K
NPJ Schizophr; 2017; 3():7. PubMed ID: 28560253
[TBL] [Abstract][Full Text] [Related]
18. ErbB4-neuregulin signaling modulates synapse development and dendritic arborization through distinct mechanisms.
Krivosheya D; Tapia L; Levinson JN; Huang K; Kang Y; Hines R; Ting AK; Craig AM; Mei L; Bamji SX; El-Husseini A
J Biol Chem; 2008 Nov; 283(47):32944-56. PubMed ID: 18819924
[TBL] [Abstract][Full Text] [Related]
19. Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategy.
Law AJ; Wang Y; Sei Y; O'Donnell P; Piantadosi P; Papaleo F; Straub RE; Huang W; Thomas CJ; Vakkalanka R; Besterman AD; Lipska BK; Hyde TM; Harrison PJ; Kleinman JE; Weinberger DR
Proc Natl Acad Sci U S A; 2012 Jul; 109(30):12165-70. PubMed ID: 22689948
[TBL] [Abstract][Full Text] [Related]
20. Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.
Deng C; Pan B; Engel M; Huang XF
Psychopharmacology (Berl); 2013 Mar; 226(2):201-15. PubMed ID: 23389757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
